Tricuspid Valve Disease

This book provides a comprehensive overview of the physiology, pathophysiology, diagnosis, medical and surgical management, and future therapies for tricuspid valve disease. It is divided into two sections. The first section covers the basics of the tricuspid valve, including anatomy, epidemiology, and clinical diagnosis with individual chapters focused on hemodynamics, echocardiography, MRI, and CT assessment. The second section examines current treatments for tricuspid valve disease including both surgical and medical management. It discusses special clinical scenarios of tricuspid valve pathology such as tricuspid regurgitation in patients with ICD and pacemaker implants and the role of tricuspid valve disease in patients with heart failure and LVAD therapy. Tricuspid Valve Disease: A Comprehensive Guide to Evaluation and Management is an essential resource for general cardiologists, interventional cardiologists, cardiac surgeons, and innovators in the field of structural heart disease.

​This book provides a comprehensive overview of tricuspid valve disease and an overview of different therapeutic options such as surgical and percutaneous approaches, current clinical trials and registries in the field of tricuspid valve disease. The book has an educational goal with key messages highlighted at the end of each chapter to assist comprehension of the often complex concepts. Practical Manual of Tricuspid Valve Diseases assists the clinician in dealing with different manifestations of tricuspid valve disease and providing help for choosing the best option for the management of these patients. It therefore serves as the standard reference regarding all aspects of tricuspid valve disease in adults and will be of importance to all medical professionals involved in the management of these patients.

"A Handbook of Tricuspid And Pulmonary Valve Disease" contains a detailed description of the diseases of these two valves. A detailed description of Ebstein's Anomaly Of Tricuspid vale is highlight of this book. Etiology, pathogenesis and hemodynamics of diseases of both valves have been dealt in simple and comprehensible manner. Special effort has been made to explain the clinical features (Symptoms and signs) of disease. Probably the clinical features is the forgotten art in the newer text books. However, the author has taken a special interest to include a detailed description of clinical features. The treatment section includes description about the various interventions (catheter based as well as surgical) and it also includes the ACC / AHA guidelines. Like his previous two handbooks (A handbook of Rheumatic Fever and A Handbook of Aortic valve Disease), this book also has extensive description of all aspects of the disease. A small chapter about 'Straight Back Syndrome' has also been included in this book. All in all, the book promises to be a great reference book for Aortic Valve disease and is worth having it on shelf for easy reading. The point wise and concise writing has made this book specially useful for students and exam going students

This book is devoted solely to the tricuspid valve and its role in congenital heart disease. Tricuspid valve anomalies are part of the pathological spectrum in various congenital heart diseases, including Ebstein anomaly and tricuspid valve dysplasia, with different pathophysiology and clinical implications. This book covers all relevant aspects of such anomalies, including diagnosis, therapy and follow-up. Further topics addressed include the way in which the tricuspid valve may become the “systemic” valve in some congenital diseases, with important consequences and the involvement of the tricuspid valve in the right-sided heart complications often seen in adults with congenital heart disease. All of the chapters are written by internationally recognized experts and are designed to deliver state of the art knowledge of practical value. This book will be an important addition to the library for surgeons, cardiologists and other practitioners involved in the management of patients with congenital heart disease.

This book provides a state-of-the-art description of the pathophysiology, diagnosis and management of valvular heart disease (VHD). With an aging population, the incidence and complexity of VHD has markedly increased and the introduction of transcatheter valve therapies have revolutionized the management of these frequent and serious cardiovascular diseases. The development of percutaneous valve interventions has revolutionized the management of VHD (or has dramatically changed its management) Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.

Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions. With the development of potential new treatments, it is crucial for cardiac physicians to be well informed on the pathophysiology, assessment, treatment options and their outcomes of valvular diseases. Written by a highly experienced and internationally recognized group of cardiologists, cardiac surgeons, and researchers, Valvular Heart Disease offers insights into the widely varying hemodynamic effects and clinical course of heart valve conditions, as well as the contemporary management of these conditions. Offering a broad perspective on these diseases, Valvular Heart Disease expands on the recent guidelines developed by the major heart societies in the United State and Europe.

Severe tricuspid regurgitation (TR) is a common valvular heart disease with an incidence of approximately 4% in the adult general population. Most commonly, it results from secondary causes including left ventricular dysfunction, mitral regurgitation and pulmonary arterial hypertension. Isolated severe TR has been identified as an independent predictor of death and cardiac adverse events. Furthermore, TR has been observed to develop late after left-sided valve surgery in up to 10% of patients with adverse impact on clinical outcomes. Perioperative mortality after surgical correction of TR has been reported to range between 2 and 10%. Moreover, a relevant proportion of patients with TR have already undergone open-heart surgical procedures and reoperation has been associated with an excessive risk of mortality. As a result, less invasive treatment options using transcatheter techniques may address an unmet need among high risk and inoperable patients. Different concepts for the percutaneous treatment of symptomatic severe TR have been developed including annular reduction, restoration of coaptation, and edge-to-edge repair. Worldwide, an increasing number of patients is treated using these emerging techniques and early clinical results begin to be available.

Portable and clinically oriented, this full-color handbook is a unique and timely guide to valvular heart disease and percutaneous coronary interventions. A structured, standardized format helps you quickly find the information you need, while numerous illustrations and videos online provide visual support for key concepts and procedures.